OasisLMS

Note: Participants have until December 31, 2022 to complete this module.

During this program our presenters will discuss evidence supporting the value of timely therapy optimization to achieving glycemic targets and the legacy effect in type 2 diabetes. This discussion will focus on integrating the ADA type 2 diabetes medication algorithm with effective intensification and deintensification guidance for reducing therapeutic inertia. In order to encourage collaborative decision making between patients, team members, and primary care providers, presenters will provide practical techniques for how and when to use new tools and technology. These include CGM, time in range, and updated medication delivery systems. 

Instructors: Davida F. Kruger, MSN, APN-BC, BC-ADM and Meltem Zeytinoglu, MD, MBA

Learning objectives:

• Understand evidence supporting the legacy effect of reaching glycemic targets and  A1C goal quickly after diagnosis.

• Describe the optimal process for intensifying and deintensifying medication therapy that quickly and effectively yields optimal diabetes targets in type 2 diabetes.

• Define how decision support tools and technology can be used to assist the patient-provider team in achieving glycemic targets and overall health.

About Instructors:

Meltem Zeytinoglu, MD, MBA, is currently an Assistant Professor of Medicine and the Adult Endocrinology, Diabetes, & Metabolism Fellowship Program Director at the University of Chicago Pritzker School of Medicine. She also serves on the American Diabetes Association’s Early Career Advisory Group and has been involved in the ADA’s Focus on Fellows program since it was started. Her clinical and research practices focus on diabetes and osteoporosis in older adults.

Davida F. Kruger, MSN, APN-BC, BC-ADM has been a certified nurse practitioner in diabetes for more then 35 years at Henry Ford Health System in Detroit, Michigan. Her role includes both clinical practice and research. She is past Chair of the American Diabetes Associations Research Foundation and has served on the American Diabetes Association's Research Policy Committee. She is also a past president, health Care and Education of the American Diabetes Association. She served as editor of Diabetes Spectrum from 2005-2008. She served as the Editor In Chief of Clinical Diabetes from 2011-2016. Ms Kruger has been a principal investigator on numerous research projects and has written widely on diabetes care, authoring the book The Diabetes Travel Guide 2nd edition (2006).